Why do we need a new approach to biosecurity?

Biology doesn’t respect borders

Public health is influenced by everything around us: people, animals, and the environment. Recognizing and using those connections for everyone’s benefit is called One Health.

Biosecurity can act like radar for One Health by helping to identify and track infectious disease variants and surges to contain potential outbreaks. This type of data sharing can empower government officials and community leaders to make informed decisions to boost our global public health systems.

The goal of biosecurity is to utilize public health data to mitigate risks and build more resilient, flourishing communities.
  • Open schools
  • Plentiful healthcare capacity
  • Productive workforce
  • Freedom to travel
  • Informed masking and distancing policies
  • Thriving commerce

We can never be caught off guard again

We’ve had evolving public health threats for over four billion years. There are more than 200 new epidemics each year, a number that has increased every year for the past two decades. By the time we put COVID-19 behind us, a new virus could emerge. We have the tools to avoid another massive pandemic disruption. Now is the time to implement them worldwide.

Sources: New York Times, CDC, WHO
Sources: New York Times, CDC, WHO

The bioeconomy is expanding

Biology is the most advanced technology on the planet. We can program cells to grow heartier crops, clean pollutants in the environment, improve energy efficiency, and more. Responsible approaches to biosecurity make sure it’s done right. Concentric by Ginkgo – the biosecurity and public health arm of Ginkgo Bioworks – partners with communities to secure the biology around us with care.

Part of our mission includes developing new kinds of biosecurity monitoring tools and data, as well as infrastructure to support this technology, to monitor for current and future pathogens with pandemic and epidemic potential.

As governments and industry continue to adopt biotechnology, we’re creating biosecurity solutions that ensure ethical, equitable scaling. Building capacity for genomic and viral sequencing is paramount, but not at the expense of privacy and data security. We must innovate with protections for communities and resources in mind. That will allow us to harness the bioeconomy’s potential while remaining agile enough to adapt to public concerns.

Biosecurity starts with systems integration

Working alongside partners in the public and private sector, industry, data, and production gives us unique insight into the challenges many sectors face integrating existing systems with biosecurity and public health. Our end-to-end platform connects capabilities and products from various providers to create networks and enhance capacity for detecting, intercepting, and mitigating pathogens. We put the people, supplies, and logistics in place for public health data at scale. Streamlined data collection and reporting systems enhance our partners’ real-time public health decision-making.

Ginkgo’s Foundry supercharges our platform

Concentric is the biosecurity and public health offering of Ginkgo Bioworks, the leading horizontal platform for cell programming. Working together gives us the power to add biosecurity at the point of design.

Ginkgo’s foundry is home to the best of DNA synthesis, sequencing, laboratory automation, and high-performance analytics. It’s where we sequenced the first instances of Omicron BA.2 and BA.3 in the U.S. as part of the CDC’s traveler-based early detection program. Building our platform around the foundry magnifies our knowledge of genomics. What we learn there can help accelerate effective responses (like vaccine development) and ensure we are building proper safety and security measures into new technologies from the start.

We built a foundation for the future

Launching the country’s COVID-19 response network called for a monumental cross-sector effort and we must maintain the systems that we built—they are working. Expanding regular testing within a layered approach to biosecurity and public health can maintain our readiness for future surges. Introducing passive monitoring testing, such as wastewater and air monitoring surveillance, will broaden our view. The additional insights can drive policies that enable communities to continually step up instead of shutting down.

Many people are ready to leave COVID-19 in the past. Now, let’s scale the innovation that got us through the pandemic to prepare for whatever pathogen might be next. One Health depends on it.

We do our best work partnering with communities to design biosecurity around specific challenges. Let’s help solve yours.

Volunteered samples…led to the first reported instances of omicron sub-lineage BA.2 and BA.3 in the U.S.

We rolled out across 100+ locations over a two-month timespan, starting with our early adopters

Consistent testing has helped restore the peace of mind that was missing at the height of the pandemic…

Instead of just having to make blanket district-wide decisions, we actually have live-time data..

Contract vehicles

Army JE-RDAP

Ginkgo Bioworks Prime Contract #: W911QY18D0068
Business Size: Small Business
Ceiling: $8.27B
Description: The Joint Enterprise Research, Development, Acquisition and Production and Procurement (JE-RDAP) program supports the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD). JPEO-CBD will use this Omnibus Vehicle for the majority of its future task/delivery order needs in support of emerging chemical, biological, radiological, nuclear, and high-yield explosives (CBRNE) defense systems, capabilities, equipment, supplies and material requirements for the U.S. Armed Forces. JE-RDAP task orders will encompass activities spanning all acquisition phases as described in DODI 5000.02: Materiel Development Decision, Materiel Solution Analysis, Technical Maturation/Risk Reduction, and Production and Deployment.

Medical CBRN Defense Consortium (MCDC) OTA

Medical CBRN Defense Consortium (MCDC) OTA: W15QKN-16-9-1002
Status: Member in good standing
Business Size: Ginkgo is a Small Business, Non-Traditional Contractor
Description: Through the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), the Medical Countermeasures Systems (MCS) Joint Project Management Office is always looking for innovative, safe and effective medical solutions to counter CBRN threats. The usage of an OTA allows government to partner with the MCDC to leverage cutting edge R&D and develop prototypes from commercial sources. This gives MCS an agile and flexible way to develop medical countermeasures using new and innovative technology. The MCDC provides the flexibility for better public and private collaboration by providing access to innovative concepts, ideas, and technologies from traditional and non-traditional technology providers.

Countering Weapons of Mass Destruction (CWMD) Consortium OTA

Countering Weapons of Mass Destruction (CWMD) Consortium OTA
Status: Member in good standing
Business Size: Ginkgo is a Small Business, Non-Traditional Contractor
Description: The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) is always looking for innovative and effective solutions to counter weapons of mass destruction. The usage of an OTA allows government to partner with the CWMD to leverage cutting edge R&D and develop prototypes from commercial sources. This gives agencies an agile and flexible way to develop CWMD prototypes using new and innovative technology. The CWMD provides the flexibility for better public and private collaboration by providing access to innovative concepts, ideas, and technologies from traditional and non-traditional technology providers.

Please contact us for more on contract vehicles or partnership opportunities.

Get in Touch